Literature DB >> 23400814

[Radiological diagnostics of meningiomas].

M Batra1.   

Abstract

Magnetic resonance imaging (MRI) is the method of choice for the diagnosis of sphenoid wing meningiomas. The close relationship situation to vascular and neural structures especially at the skull base can best be assessed with MRI. With a typical configuration and extent the diagnosis of meningiomas can be made on visual examination and MRI is also the standard imaging technique for follow-up of treated and asymptomatic meningiomas. In the preoperative evaluation, computed tomography is a complementary examination technique which can demonstrate the extent and type of bone involvement more precisely. This additional information is important to differentiate meningiomas from differential diagnoses, such as metastases, sarcomas, and primary osseous changes, such as fibrous dysplasia or Paget's disease. Positron emission tomography computed tomography (PET-CT) and PET-MRI are also supplemental examination procedures which can be used for determining tumor volume before a planned radiotherapy and can be helpful in the diagnosis of atypical meningiomas due to the selective binding of the tracer DOTATOC. Conventional angiography is only rarely used preoperatively.

Entities:  

Mesh:

Year:  2013        PMID: 23400814     DOI: 10.1007/s00347-012-2702-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  18 in total

1.  Incidental findings on brain MRI in the general population.

Authors:  Meike W Vernooij; M Arfan Ikram; Hervé L Tanghe; Arnaud J P E Vincent; Albert Hofman; Gabriel P Krestin; Wiro J Niessen; Monique M B Breteler; Aad van der Lugt
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

2.  PET/MRI: paving the way for the next generation of clinical multimodality imaging applications.

Authors:  Bernd J Pichler; Armin Kolb; Thomas Nägele; Heinz-Peter Schlemmer
Journal:  J Nucl Med       Date:  2010-02-11       Impact factor: 10.057

Review 3.  Positron emission tomography imaging of meningioma in clinical practice: review of literature and future directions.

Authors:  Jan Frederick Cornelius; Karl Josef Langen; Gabriele Stoffels; Daniel Hänggi; Michael Sabel; Hans Jakob Steiger
Journal:  Neurosurgery       Date:  2012-04       Impact factor: 4.654

4.  Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas.

Authors:  C Majós; J Alonso; C Aguilera; M Serrallonga; S Coll; J J Acebes; C Arús; J Gili
Journal:  Neuroradiology       Date:  2003-02-19       Impact factor: 2.804

5.  Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.

Authors:  A Shino; S Nakasu; M Matsuda; J Handa; S Morikawa; T Inubushi
Journal:  J Neurosurg       Date:  1999-12       Impact factor: 5.115

6.  Management of meningiomas en plaque of the sphenoid wing.

Authors:  Uta Schick; Joris Bleyen; Alan Bani; Werner Hassler
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

7.  Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.

Authors:  Andreas Boss; Sotirios Bisdas; Armin Kolb; Matthias Hofmann; Ulrike Ernemann; Claus D Claussen; Christina Pfannenberg; Bernd J Pichler; Matthias Reimold; Lars Stegger
Journal:  J Nucl Med       Date:  2010-07-21       Impact factor: 10.057

8.  MR spectroscopy in patients with intracranial meningiomas.

Authors:  R Buhl; A Nabavi; S Wolff; H H Hugo; K Alfke; O Jansen; H M Mehdorn
Journal:  Neurol Res       Date:  2007-01       Impact factor: 2.448

9.  Preoperative neuroimaging findings as a predictor of the surgical plane of cleavage: prospective study of 100 consecutive cases of intracranial meningioma.

Authors:  Jorge E Alvernia; Marc P Sindou
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

10.  [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.

Authors:  Barbara Gehler; Frank Paulsen; Mehmet O Oksüz; Till-Karsten Hauser; Susanne M Eschmann; Roland Bares; Christina Pfannenberg; Michael Bamberg; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2009-11-18       Impact factor: 3.481

View more
  1 in total

1.  [Visual impairment due to rare optic nerve tumor].

Authors:  J Lenk; E Matthé; D Sandner
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.